Kenneth P.
Fallon, III has served as a director of Osteotech since June 1995, and as Chairman of the Board since November 2005. Since March 2004, Mr. Fallon has been an Associate with Kairos Partners, an investment firm and a stockholder that owns approximately 9.2% of the Company's outstanding stock. Mr. Fallon retired as the Chairman of the Board of Axya Medical, Inc., a Massachusetts based privately held medical device company, in March 2003 and was the Chief Executive Officer of Axya Medical Inc., from May 1999 until December 2002. In 1997 and 1998, Mr. Fallon was President of the surgical business at Haemonetics Corporation. In 1994 and 1995, Mr. Fallon served as Chief Executive Officer and Chairman of the Board of UltraCision, Inc., a developer and manufacturer of ultrasonically powered surgical instruments. UltraCision, Inc. was sold to Ethicon EndoSurgery, a unit of Johnson & Johnson, Inc., in November 1995. From 1992 through 1994, Mr. Fallon served as President and Chief Executive Officer of American Surgical Technologies Corporation. Mr. Fallon was President, U.S. Operations of Zimmer, Inc., then a subsidiary of Bristol-Myers Squibb Company from 1991 to 1992. From 1985 through 1991 he served as President of Zimmer's Orthopaedic Implant Division, and from 1983 to 1985 as its Vice President of Marketing. Mr. Fallon previously served in positions of significant responsibility with the Codman and Orthopedic Divisions of Johnson & Johnson, Inc. Mr. Fallon is also a director of Conformis Inc., a privately held medical device firm. Mr. Fallon has a B.B.A. degree in marketing from the University of Massachusetts and an M.B.A. degree from Northeastern University.
Sam Owusu-Akyaw joined Osteotech in July 2004 as President and Chief Operating Officer and a member of the Board. Since January 2006, he has served in his current position of President, Chief Executive Officer and Director. Prior to joining Osteotech, Mr. Owusu-Akyaw served as General Manager of Medtronic Midas Rex and Vice President of Medtronic, Inc. from 2000 through June 2004, and Chief Operating Officer of Medtronic Midas Rex from 1999 to 2000. Mr. Owusu-Akyaw was Vice President of Operations of DePuy-Acromed, a Johnson & Johnson Company, from 1998 to 1999 and Vice President of Acromed, Inc. from 1996 to 1998. Mr. Owusu-Akyaw was Vice President, BMS Productivity for Growth Initiative of Bristol-Myers Squibb Company from 1994 to 1996. From 1977 to 1994, Mr. Owusu-Akyaw served in positions of increasing responsibility with Zimmer, Inc., then a subsidiary of Bristol-Myers Squibb Company. Mr. Owusu-Akyaw has a B.A. degree in accounting and computer science from Manchester College and an M.B.A. in finance and operations from the University of Houston.
Stephen S.
Galliker has served as a director of Osteotech since March 2004. Mr. Galliker served as Executive Vice President, Finance and Administration, and Chief Financial Officer of Dyax Corp., a biopharmaceutical company from September, 1999 until his retirement in July, 2008. He was Chief Financial Officer of Excel Switching Corporation, a developer and manufacturer of open switching platforms for telecommunications networks, from July 1996 to September 1999, and was Excel's Vice President, Finance and Administration from September 1997 to September 1999. Mr. Galliker was employed by UltraCision, Inc., a developer and manufacturer of ultrasonically powered surgical instruments from September 1992 to June 1996. At UltraCision, Inc., Mr. Galliker was Chief Financial Officer and Vice President of Finance until November 1995 and Chief Operating Officer from December 1995 to June 1996. In addition, Mr. Galliker has been a director of RXi Pharmaceuticals, a publicly held biopharmaceutical company, since 2007. Mr. Galliker has a B.S.B.A. in management and finance from Georgetown University and an M.B.A. from the University of Chicago.
Robert J.
Palmisano has served as a director of Osteotech since March 2005. Mr. Palmisano is currently the President and Chief Executive Officer of ev3, Inc., a medical device company focused on catheter-based technologies for the endovascular treatment of vascular diseases and disorders. From November 2007 until April 2008, Mr. Palmisano was a venture partner with SV Life Sciences in Boston, Massachussets. From April 2003 until April 2008, Mr. Palmisano was the President, Chief Executive Officer and a director of IntraLase Corp., a company engaged in the design, development and manufacture of laser products for vision correction, which was acquired by Advanced Medical Optics, Inc. in April 2007. Prior to joining IntraLase, from April 2001 to April 2003, Mr. Palmisano was the President, Chief Executive Officer and a director of MacroChem Corporation, a development stage pharmaceutical corporation. From April 1997 to January 2001, Mr. Palmisano served as President and Chief Executive Officer and a director of Summit Autonomous, Inc., a global medical products company that was acquired by Alcon, Inc. in October 2000. Prior to 1997, Mr. Palmisano held various executive positions with Bausch & Lomb Incorporated, a global eye care company. In addition, Mr. Palmisano has been a director of OraMetrix, Inc. since October 2005 and ev3, Inc. since April 2008. Mr. Palmisano has a B.A. degree in Political Science from Providence College.
James M.
Shannon has served as a director of Osteotech since March 2007. Since June 2002, Mr. Shannon has been the President and Chief Executive Officer of the National Fire Protection Association (the "NFPA"), an international organization which is the world's leading advocate for fire prevention, providing and developing codes and standards, research, training and education. From 1991 until June 2002, he was Senior Vice President and General Counsel of NFPA. Formerly, Mr. Shannon was the Attorney General of the Commonwealth of Massachusetts from 1987 to 1991 and a Senior Partner at the law firm of Hale & Dorr from 1985 to 1987. From 1979 to 1985, Mr. Shannon represented the Commonwealth of Massachusetts in the U.S. House of Representatives, where he served as a member of the Ways and Means Committee for six years and served on the Trade, Health and Social Security Subcommittees. Mr. Shannon has a B.A. degree from Johns Hopkins University and a J.D. from George Washington University.
Robert M.
Wynalek joined
Osteotech in September 2004 and was elected
President Domestic in April 2006. From
September 2004 to April 2006, Mr. Wynalek
served as Senior Vice President Sales & Marketing.
Prior to joining Osteotech, Mr. Wynalek
had more than 23 years sales and marketing
experience in the medical device and
related industries. Mr. Wynalek served
as Vice President of Marketing for Medtronic
Powered Surgical Solutions from April
1999 until September 2004, and as Director,
Powered Surgical Systems, a division
of Medtronic Sofamor Danek, from June
1996 until April 1999. From September
1990 until June 1996 Mr. Wynalek served
in positions of increasing responsibility
with Smith & Nephew Orthopaedics. From
June 1981 until September 1990 Mr. Wynalek
held positions with Becton Dickinson
and Company and Levor Brothers Company.
Mr. Wynalek has a B.S.B.A. in Marketing
from Bowling Green University.
Mark H. Burroughs has served as the Company's Executive Vice President, Chief Financial Officer since January 2006. Mr. Burroughs joined Osteotech in November 2000 as Vice President Finance and Treasurer. Prior to joining Osteotech, Mr. Burroughs was Senior Vice President, Finance for MEDIQ/PRN Life Support Services, Inc. During his nine-year tenure with MEDIQ/PRN, from November 1992 to October 2000, Mr. Burroughs served in a variety of executive level capacities in finance, operations, business development and mergers and acquisitions. Previously, Mr. Burroughs held positions of increasing responsibility for nine years with Deloitte & Touche. Mr. Burroughs is a Certified Public Accountant and has a B.S. in accounting from Montclair State University.
Donna A.
Haag has
served as the Company's Vice President
Supply Chain since April 2006. Ms. Haag joined Osteotech
in July 1989, originally as Operations
Manager and held the positions of Director
Operations and Senior Director Operations
through October 1997. From October 1997
through December 2000, Ms. Haag held
the position of Senior Director Operations
Engineering and Technology. From January
2001 through June 2004, Ms Haag held
the position of Senior Director New Business
Development. From June 2004 through December
2004 she held the position of Senior
Director Marketing and from January to
April 2006 she served as Vice President
Supply Chain and Distribution. Prior
to joining Osteotech, Ms. Haag was a
Project Manager for the Technical Operations
Division of E.R. Squibb & Sons. Ms. Haag
has a B.S.E. degree from the University
of Pennsylvania and a M.S. degree in
management science from Stevens Institute
of Technology.
Roman Hitchev,
M.D., C.P.T.C., Vice President International
and Managing Director and President OsteoCentre
Bulgaria, joined Osteotech in May 2002.
Prior to joining Osteotech, Dr. Hitchev
was the Executive Director of the Lions
Eye and Tissue Bank. Dr. Hitchev has 11
years experience in organ and tissue procurement.
In 2004 Dr. Hitchev was elected President
of the Bulgarian Association of Tissue
Banks and in 2005 was elected as a Board
Member of the European Association of Tissue
Banks (EATB) and subsequently elected President
of the 15th Congress of the EATB. Dr. Hitchev
is a member of the American Association
of Tissue Banks, National Association of
Transplant Coordinators and the American
College of Physician Executives. Dr. Hitchev
has an M.D. degree from the Varna Medical
School and since 1998 has been board certified
as a Certified Transplant Procurement Coordinator
by the American Board for Transplant Certification.
Robert W.
Honneffer joined
Osteotech in September 2004 and was elected
Senior Vice President Operations in April
2006. From December 2004 to April 2006
Mr. Honneffer served as Vice President
Operations and from September 2004 to
December 2004 he served as Vice President
Supply Chain & Distribution. Mr. Honneffer
has over 30 years of diversified medical
device experience. Immediately prior
to joining Osteotech, Mr. Honneffer served
as Director of Customer Services and
Technical Support at Medtronic Powered
Surgical Solutions. Prior to Medtronic,
Mr. Honneffer held positions in business
development and general management with
CASurgica Inc., OrtoMaquet AG, and Unique
Instruments Inc. From 1973 until 1997
Mr. Honneffer held various positions
of increasing responsibility with Zimmer,
Inc., then a division of Bristol-Myers
Squibb Inc. Mr. Honneffer has an M.S.
in Business Administration from St. Francis
College and a B.S. in Mechanical Engineering
from Youngstown State University.
Kai H. Lo joined Osteotech in August 2005 as Vice President/Controller Domestic Operations. In 2008, Mr. Lo assumed the position of Vice President, Strategic/Business Planning and Sales Administration. Prior to joining Osteotech, Mr. Lo was Division Controller for Medtronic Midas Rex from 2001 through August 2005. From 1999 through 2001 Mr. Lo held the position of Corporate Controller at Saltmine, a privately held web development and consulting company. Prior to 1999, Mr. Lo held various positions of responsibility in diverse companies and industries, including DePuy AcroMed, The Wilkinson Company and Nationwide Insurance. Mr. Lo has a B.S. in Finance and an M.B.A. in Finance and International Business from The Ohio State University as well as an MS in Economics from The Cleveland State University.
Martin Rexroad joined Osteotech on April 9, 2007 as Vice President, Human Resources. Prior to joining Osteotech, Mr. Rexroad served as Vice President, HR Service Center at New York Life Insurance Company where he was responsible for Recruiting, Talent Management Support, Benefits Administration, Payroll, HR Systems, and Project Management. Prior to joining New York Life Insurance in 2005, Mr. Rexroad worked for Altria Corporate Services, Inc. and Philip Morris USA for over 17 years. At Altria Corporate Services, Inc., Mr. Rexroad served as Director, HR Development where he was a key team member responsible for designing and deploying a global talent management system and managing a global support organization. At Philip Morris USA, Mr. Rexroad was Director Strategic Staffing; Director, HR Decision Support - Northeast Sales Region; Manager, HR Operations; and Labor Relations Specialist. Mr. Rexroad also worked in Management and Organization Development, Compensation and Benefits. Mr. Rexroad is a member of the Society of HR Management and the HR Planning Society. Mr. Rexroad has a M.S. in Human Resources and Labor Relations and a B.S. in Business Management from Virginia Polytechnic Institute and State University.
Greg Cannedy joined Osteotech in May, 2006 as the Senior Director, Quality Assurance and Regulatory Affairs and was elected Vice President, Quality Assurance, Regulatory Affairs & Good Tissue Practices in May, 2007. Prior to joining Osteotech, Mr. Cannedy has over 20 years in the areas of regulatory affairs, quality systems, compliance and clinical affairs. Mr. Cannedy has consulted to both the IVD and medical device industries. Mr. Cannedy served as the Director, Regulatory Affairs for Medtronic Powered Surgical Solutions, and as a Senior Regulatory/Clinical Affairs Principle at DePuy-Acromed (a Johnson & Johnson Company). Mr. Cannedy was a sales representative for API and has held various clinical laboratory positions. Mr. Cannedy holds an EMBA from Cleveland State University and has a Bachelor's of Science in Medical Technology from Old Dominion University.
|
